The effectiveness of Hydroxy-Methylglutaryl Coenzyme A reductase inhibitors in the elderly is not influenced by Apolipoprotein E-genotypes
Publication date
2002
Authors
Maitland-van der Zee, Anke H
Stricker, B.H.Ch.
Klungel, O H
Kastelein, J.J.P.
Hofman, A.
Witteman, J.C.M.
Breteler, M.M.B.
Leufkens, Hubert G.M.
van Duijn, C.M.
de Boer, A
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Keywords
Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health, SDG 3 - Good Health and Well-being
Citation
Maitland-van der Zee, A H, Stricker, B H C, Klungel, O H, Kastelein, J J P, Hofman, A, Witteman, J C M, Breteler, M M B, Leufkens, H G M, van Duijn, C M & de Boer, A 2002, 'The effectiveness of Hydroxy-Methylglutaryl Coenzyme A reductase inhibitors in the elderly is not influenced by Apolipoprotein E-genotypes', Pharmacogenetics, vol. 12, no. 8, pp. 647-653.